Market Research Logo

Indonesia Pharmaceuticals & Healthcare Q4 2018

Indonesia Pharmaceuticals & Healthcare Q4 2018

Key View:

We do not expect Indonesia to achieve its goal of having universal healthcare by 2019. While significant progress hasbeen made in growing enrolment into the national health insurance scheme (JKN), further expansion will be hampered by deficit,investment shortages and uneven levels of healthcare access across the country. Additionally, for the pharmaceutical industry, theJKN's positive impact on growth is likely to wane over the medium term, as the scheme focuses on sales of low-cost generic drugs.Still, Indonesia's substantial population numbers, its epidemiological profile the emerging middle class will continue to offersignificant commercial opportunities for multinationals.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals & Healthcare Risk/Reward Index
Indonesia Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Industry Trends And Developments
Market Overview
Competitive Landscape
Company Profile
Bayer
Darya-Varia Group
GlaxoSmithKline
Indofarma
Kimia Farma
Merck & Co
Merck Group
Novartis
Pfizer
PT Bio Farma
PT Kalbe Farma
Sanofi
Soho Global Healthcare Group
Indonesia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report